oxybutynin has been researched along with Adenopathy in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afra, TP | 1 |
| Namitha, R | 1 |
| Khader, A | 1 |
| Bishnoi, A | 1 |
| Shahul Hameed, DK | 1 |
| Razmi T, M | 1 |
1 other study available for oxybutynin and Adenopathy
| Article | Year |
|---|---|
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: erythrocyanotic vascular patches associated with an underlying rib plasmacytoma.
Topics: Bone Neoplasms; Humans; Lymphadenopathy; Plasmacytoma; Ribs; Syndrome; Transdermal Patch | 2020 |